Hippocampal degeneration is associated with GFAP levels in individuals with vascular dementia independently of amyloidosis

Our findings suggest that astrocyte reactivity, as indicated by plasma GFAP levels, plays a significant role in the hippocampal atrophy observed in patients with vascular disease. These results suggest that therapies targeting astrocyte reactivity could potentially alleviate progressive cognitive deficits commonly found in patients with chronic vasculopathy.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.092720
Primary Topic
Neurological Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hippocampal degeneration is associated with GFAP levels in individuals with vascular dementia independently of amyloidosis

Hyun Woong Roh, Dana Tudorascu, Tharick Ali Pascoal, Joseph Therriault et al.
Alzheimer s & Dementia
Neurological Disorders and Treatments
article

Hippocampal degeneration is associated with GFAP levels in individuals with vascular dementia independently of amyloidosis

Hyun Woong Roh, Dana Tudorascu, Tharick Ali Pascoal, Joseph Therriault, Nicholas James Ashton, Cynthia Felix, Guilherme Povala, Douglas Teixeira Leffa, Eduardo Rigon Zimmer, Chang Hyung Hong, Carolina Soares, Sang Joon Son, Guilherme Bauer‐Negrini, Nesrine Rahmouni, Pâmela C.L. Ferreira, Emma Patrice Ruppert, Andréa Lessa Benedet, Matheus Scarpatto Rodrigues, Thomas K. Karikari, Stijn Servaes, Bruna Bellaver, Sarah Abbas, Firoza Zubeida Lussier, Cécile Tissot, Hussein Zalzale, Kaj Blennow, Henrik Zetterberg, Andréia Silva da Rocha, Francieli Rohden, Pedro Rosa‐Neto, Pampa Saha, Jenna Stevenson, Vanessa Machado, Markley S. Oliveira
article en

Abstract

Our findings suggest that astrocyte reactivity, as indicated by plasma GFAP levels, plays a significant role in the hippocampal atrophy observed in patients with vascular disease. These results suggest that therapies targeting astrocyte reactivity could potentially alleviate progressive cognitive deficits commonly found in patients with chronic vasculopathy.

Alzheimer s & DementiaVol. 20(S1)
Universidade Federal do Rio Grande do Sul (BR), University of Wisconsin–Madison (US), Lawrence Berkeley National Laboratory (US), University of Pittsburgh (US), McGill University Health Centre (CA), Instituto do Cérebro (BR), UK Dementia Research Institute (GB), University College London (GB), McGill University (CA), Ajou University (KR), University of Gothenburg (SE)
Openalex Percentile: Top 72%
Neurological Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.